These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1689200)

  • 41. Two classes of binding sites for [3H]substance P in rat cerebral cortex.
    Geraghty DP; Burcher E
    Brain Res; 1993 Jan; 601(1-2):34-40. PubMed ID: 7679311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
    Hirayama Y; Lei YH; Barnes PJ; Rogers DF
    Br J Pharmacol; 1993 Mar; 108(3):844-51. PubMed ID: 7682142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors.
    Brunelleschi S; Vanni L; Ledda F; Giotti A; Maggi CA; Fantozzi R
    Br J Pharmacol; 1990 Jul; 100(3):417-20. PubMed ID: 1697194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The mechanism of tachykinin-induced bronchoconstriction in the rat.
    Joos GF; Pauwels RA; van der Straeten ME
    Am Rev Respir Dis; 1988 May; 137(5):1038-44. PubMed ID: 2461668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FR 113680: a novel tripeptide substance P antagonist with NK1 receptor selectivity.
    Morimoto H; Murai M; Maeda Y; Hagiwara D; Miyake H; Matsuo M; Fujii T
    Br J Pharmacol; 1992 May; 106(1):123-6. PubMed ID: 1380378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra.
    Humpel C; Saria A
    Neurosci Lett; 1989 Oct; 105(1-2):159-63. PubMed ID: 2484728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuropeptide K and neurokinin A stimulate CRH and ACTH release by rat adrenal medulla in vitro.
    Mazzocchi G; Malendowicz LK; Gottardo G; Nussdorfer GG
    Peptides; 1997; 18(4):487-90. PubMed ID: 9210165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tachykinin effects on bladder activity in conscious normal rats.
    Ishizuka O; Mattiasson A; Andersson KE
    J Urol; 1995 Jul; 154(1):257-61. PubMed ID: 7539864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Substance P and neurokinin levels are decreased in the cortex and hypothalamus of alcohol-preferring (P) rats.
    Slawecki CJ; Jimenéz-Vasquez P; Mathé AA; Ehlers CL
    J Stud Alcohol; 2001 Nov; 62(6):736-40. PubMed ID: 11838908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra.
    Lindefors N; Brodin E; Ungerstedt U
    Eur J Pharmacol; 1989 Feb; 161(1):95-8. PubMed ID: 2470596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postnatal changes in the substance P receptor on rabbit gastric smooth muscle.
    Hyman PE; Kimura S; Tomomasa T; Yuan QX; Snape WJ; McRoberts JA
    Am J Physiol; 1992 Feb; 262(2 Pt 1):G291-7. PubMed ID: 1371647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurokinin A-stimulated phosphoinositide breakdown in rabbit iris sphincter muscle.
    Taniguchi T; Ninomiya H; Fukunaga R; Ebii K; Yamamoto M; Fujiwara M
    Jpn J Pharmacol; 1992 Jun; 59(2):213-20. PubMed ID: 1279251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.
    Culman J; Wiegand B; Spitznagel H; Klee S; Unger T
    Br J Pharmacol; 1995 Mar; 114(6):1310-6. PubMed ID: 7542533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NK1 and NK2 receptors mediate tachykinin and resiniferatoxin-induced bronchospasm in guinea pigs.
    Foulon DM; Champion E; Masson P; Rodger IW; Jones TR
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):915-21. PubMed ID: 7692776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle.
    Bergström L; Beaujouan JC; Torrens Y; Saffroy M; Glowinski J; Lavielle S; Chassaing G; Marquet A; D'Orleans-Juste P; Dion S
    Mol Pharmacol; 1987 Dec; 32(6):764-71. PubMed ID: 2826990
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat.
    Lördal M; Bränström R; Hellström PM
    Br J Pharmacol; 1998 Jan; 123(1):63-70. PubMed ID: 9484855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tachykinin receptors of the NK1 type (substance P) coupled positively to phospholipase C on cortical astrocytes from the newborn mouse in primary culture.
    Torrens Y; Daguet De Montety MC; el Etr M; Beaujouan JC; Glowinski J
    J Neurochem; 1989 Jun; 52(6):1913-8. PubMed ID: 2470856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of substance P, neurokinin A and a selective agonist of tachykinin receptors of the NK-2 type on bile metabolism].
    Spivak LS; Liashchenko TP; Vesel'skiĭ SP; Makarchuk NE
    Ross Fiziol Zh Im I M Sechenova; 2003 Sep; 89(9):1167-75. PubMed ID: 14758641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tachykinin inhibition of acid-induced gastric hyperaemia in the rat.
    Heinemann A; Jocic M; Herzeg G; Holzer P
    Br J Pharmacol; 1996 Dec; 119(8):1525-32. PubMed ID: 8982497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.